LGALS3 and infectious disease: The current accumulation of new information depicts a future scenario where galectin-3 could be used as a potential anti-inflammatory mediator and a specific modulator of the immune response in inflammatory and infectious disease, possibly by regulating neutrophils and other related immune responses.